Crescent Biopharma (CBIO) Other Accumulated Expenses (2013 - 2024)
Crescent Biopharma's Other Accumulated Expenses came in at $52,948 for Q2 2024, up 156.2% from $20,670 a year earlier and up 388.8% from the prior quarter.
Powered by 
Analysis
Crescent Biopharma (CBIO) Other Accumulated Expenses (2013 - 2024) Analysis & Trends
At the end of FY2022, Crescent Biopharma's Other Accumulated Expenses was $42,406, down 53.1% from FY2021.
- Other Accumulated Expenses carries a five-year compound annual growth rate of -32.6% (FY2017 to FY2022).
- Going back by year, Other Accumulated Expenses was $90,342 in FY2021 (-59.0%), $220,469 in FY2020 (+4.5%), $210,904 in FY2019 (-20.0%) and $263,693 in FY2018 (-13.4%).
- The Q2 2024 figure represents the highest quarterly Other Accumulated Expenses since Q1 2023.
- Year-over-year, Other Accumulated Expenses increased in 1 of the last seven quarters, with an average decline of 34.0%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q2 2024 (growth of 156.2%), and the weakest in Q1 2024 (a decline of 80.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Crescent Biopharma | 397.47 Mn | -309.83 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 52,948.00 |
| Mar 31, 2024 | 10,832.00 |
| Sep 30, 2023 | 16,457.00 |
| Jun 30, 2023 | 20,670.00 |
| Mar 31, 2023 | 55,190.00 |
| Dec 31, 2022 | 42,406.00 |
| Sep 30, 2022 | 59,336.00 |
| Jun 30, 2022 | 82,426.00 |
| Mar 31, 2022 | 109,895.00 |
| Dec 31, 2021 | 90,342.00 |
| Sep 30, 2021 | 163,538.00 |
| Jun 30, 2021 | 187,966.00 |
| Mar 31, 2021 | 106,898.00 |
| Dec 31, 2020 | 220,469.00 |
| Sep 30, 2020 | 260,972.00 |
| Jun 30, 2020 | 153,917.00 |
| Mar 31, 2020 | 178,403.00 |
| Dec 31, 2019 | 210,904.00 |
| Sep 30, 2019 | 143,620.00 |
| Jun 30, 2019 | 153,340.00 |
API Access
Crescent Biopharma Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();